William T Hu
William T Hu
Associate professor, Rutgers Biomedical and Health Sciences
Verified email at rutgers.edu
Cited by
Cited by
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ...
New England Journal of Medicine 370 (4), 322-333, 2014
The future of blood-based biomarkers for Alzheimer's disease
K Henriksen, SE O’Bryant, H Hampel, JQ Trojanowski, TJ Montine, ...
Alzheimer's & Dementia 10 (1), 115-131, 2014
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Z Zhang, M Song, X Liu, SS Kang, IS Kwon, DM Duong, NT Seyfried, ...
Nature medicine 20 (11), 1254-1262, 2014
Cognitive impairment and celiac disease
WT Hu, JA Murray, MC Greenaway, JE Parisi, KA Josephs
Archives of neurology 63 (10), 1440-1446, 2006
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ...
Neurology 79 (9), 897-905, 2012
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
KA Josephs, JL Whitwell, DS Knopman, WT Hu, DA Stroh, M Baker, ...
Neurology 70 (19 Part 2), 1850-1857, 2008
Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
WT Hu, A Chen-Plotkin, SE Arnold, M Grossman, CM Clark, LM Shaw, ...
Acta neuropathologica 119 (6), 669-678, 2010
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology
KA Josephs, JL Whitwell, JR Duffy, WA Vanvoorst, EA Strand, WT Hu, ...
Neurology 70 (1), 25-34, 2008
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
JB Toledo, J Brettschneider, M Grossman, SE Arnold, WT Hu, SX Xie, ...
Acta neuropathologica 124 (1), 23-35, 2012
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease
AS Chen‐Plotkin, WT Hu, A Siderowf, D Weintraub, R Goldmann Gross, ...
Annals of neurology 69 (4), 655-663, 2011
Distinct cerebral perfusion patterns in FTLD and AD
WT Hu, Z Wang, VMY Lee, JQ Trojanowski, JA Detre, M Grossman
Neurology 75 (10), 881-888, 2010
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease
WT Hu, KA Josephs, DS Knopman, BF Boeve, DW Dickson, RC Petersen, ...
Acta neuropathologica 116 (2), 215, 2008
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration
AS Chen-Plotkin, M Martinez-Lage, PMA Sleiman, W Hu, R Greene, ...
Archives of neurology 68 (4), 488-497, 2011
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ...
Neurology 85 (8), 692-700, 2015
Poly (GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis
TF Gendron, J Chew, JN Stankowski, LR Hayes, YJ Zhang, M Prudencio, ...
Science translational medicine 9 (383), 2017
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
T Chalermpalanupap, B Kinkead, WT Hu, MP Kummer, T Hammerschmidt, ...
Alzheimer's research & therapy 5 (2), 1-9, 2013
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome
WT Hu, GW Rippon, BF Boeve, DS Knopman, RC Petersen, JE Parisi, ...
Movement disorders: official journal of the Movement Disorder Society 24 (9 …, 2009
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia
WT Hu, C McMillan, D Libon, S Leight, M Forman, VMY Lee, ...
Neurology 75 (7), 595-602, 2010
Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease
WT Hu, A Chen-Plotkin, SE Arnold, M Grossman, CM Clark, LM Shaw, ...
Acta neuropathologica 120 (3), 385-399, 2010
Survival profiles of patients with frontotemporal dementia and motor neuron disease
WT Hu, H Seelaar, KA Josephs, DS Knopman, BF Boeve, EJ Sorenson, ...
Archives of neurology 66 (11), 1359-1364, 2009
The system can't perform the operation now. Try again later.
Articles 1–20